# Evaluation of Hepatic Function Using Gadoxetic Acid Enhanced MRI

> **NCT02854371** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 54 (actual)

## Conditions studied

- Cirrhosis

## Interventions

- **DRUG:** gadoxetic acid enhanced liver MRI
- **DRUG:** ICG R15

## Key facts

- **NCT ID:** NCT02854371
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2017-02
- **Final completion:** 2018-05
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2018-11-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02854371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02854371, "Evaluation of Hepatic Function Using Gadoxetic Acid Enhanced MRI". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02854371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*